Front Desk: 469-391-0070
Lenalidomide: Uses, Dosage, and Side Effects Overview
Summary of Key Points
Lenalidomide is a prescription medication used to treat various blood cancers, including multiple myeloma, myelodysplastic syndromes, and certain types of lymphoma. It works by modulating the immune system and slowing the growth of cancer cells. Available in capsule form, Lenalidomide should be taken exactly as prescribed. Due to the potential for serious side effects, regular monitoring by your healthcare provider is essential.
Names of Medication
US Brand Name: Revlimid
Generic Name: Lenalidomide
The generic name refers to the active ingredient, while the brand name is assigned by the manufacturer. In this case, Lenalidomide is the generic name.
Pharmacologic Category
Lenalidomide belongs to several pharmacologic categories, including:
- Immunomodulatory agents
- Antineoplastic agents
- Angiogenesis inhibitors
Lenalidomide Dosage
Lenalidomide is used to treat multiple conditions, with dosing varying based on the specific disease. Always follow your doctor’s instructions and never adjust your dose without consulting your healthcare provider. If you have concerns, you can speak to one of our telemedicine providers immediately.
Lenalidomide for Multiple Myeloma
The typical starting dose for multiple myeloma is 25 mg taken orally once daily on days 1-21 of a 28-day cycle, often in combination with other medications like dexamethasone. The duration of treatment depends on your response to therapy.
Lenalidomide for Myelodysplastic Syndromes
For certain types of myelodysplastic syndromes, the usual dose is 10 mg taken once daily. Treatment continues until disease progression or unacceptable side effects occur.
Lenalidomide for Mantle Cell Lymphoma
The typical dose for mantle cell lymphoma is 25 mg taken orally once daily on days 1-21 of a 28-day cycle. Treatment may continue as long as the patient responds and tolerates the medication.
Lenalidomide for Chronic Lymphocytic Leukemia
For chronic lymphocytic leukemia (CLL), the dosing regimen is individualized based on the patient’s condition and response to treatment. Your doctor will determine the most appropriate dose for you.
Lenalidomide for Follicular Lymphoma
The usual dose for follicular lymphoma is 20 mg taken orally once daily on days 1-21 of a 28-day cycle, often in combination with other therapies.
Lenalidomide for Non-Hodgkin Lymphoma
The typical dose for non-Hodgkin lymphoma is 25 mg taken orally once daily on days 1-21 of a 28-day cycle. The duration of treatment depends on the patient’s response to therapy.
Lenalidomide for Amyloidosis
The typical dose for amyloidosis is 15 mg taken orally once daily on days 1-21 of a 28-day cycle. Your doctor will closely monitor your treatment to ensure its effectiveness and safety.
Lenalidomide for Acute Myeloid Leukemia
For acute myeloid leukemia (AML), the dose is individualized based on the patient’s specific needs and response to treatment. Consult your healthcare provider for personalized dosing.
Lenalidomide for Peripheral T-Cell Lymphoma
The usual dose for peripheral T-cell lymphoma is 25 mg taken orally once daily on days 1-21 of a 28-day cycle. Treatment may continue as long as the patient responds.
Lenalidomide for Waldenström Macroglobulinemia
The typical dose for Waldenström macroglobulinemia is 25 mg taken orally once daily on days 1-21 of a 28-day cycle. The duration of treatment depends on the patient’s response.
Dosage Forms and Strengths
Lenalidomide is available in capsule form in the following strengths:
- 2.5 mg
- 5 mg
- 10 mg
- 15 mg
- 20 mg
- 25 mg
Administration Instructions for Lenalidomide
Take Lenalidomide orally, with or without food, at the same time each day. Swallow the capsules whole with water; do not break, chew, or open them. If you miss a dose, take it as soon as you remember, unless it’s close to your next scheduled dose. In that case, skip the missed dose and take your next dose at the regular time. Do not double up on doses.
Contraindications for Lenalidomide
A contraindication is a condition or factor that makes the use of a medication unsafe. If you have any of the following conditions, you should not take Lenalidomide, as it could cause harm or worsen your condition. Always discuss your full medical history with your healthcare provider before starting any new medication.
Pregnancy: Lenalidomide can cause severe birth defects or death to an unborn baby. It is absolutely contraindicated during pregnancy. Women who are pregnant or planning to become pregnant should not take this medication.
Severe allergic reactions to Lenalidomide: If you’ve had a serious allergic reaction (such as rash, hives, or difficulty breathing) to Lenalidomide, you should not take it again, as it could lead to life-threatening complications.
Uncontrolled infections: Lenalidomide can suppress the immune system, making it harder for your body to fight infections. If you have an active, uncontrolled infection, taking Lenalidomide could worsen your condition.
Severe liver or kidney disease: Lenalidomide is processed by the liver and kidneys. If you have severe liver or kidney disease, your body may not clear the medication properly, leading to toxicity.
Lenalidomide Drug Interactions
Lenalidomide can interact with other medications, increasing the risk of side effects or reducing treatment effectiveness. Inform your healthcare provider about all medications you are currently taking, including over-the-counter drugs and supplements.
Warfarin (Coumadin): Lenalidomide may increase the risk of bleeding when taken with blood thinners like Warfarin.
Erythropoietin-stimulating agents (Epogen, Procrit): These medications, used to treat anemia, may increase the risk of blood clots when combined with Lenalidomide.
Digoxin (Lanoxin): Lenalidomide can increase Digoxin levels in your blood, leading to potential toxicity.
Ciprofloxacin (Cipro) and other fluoroquinolone antibiotics: These antibiotics may increase the risk of side effects when taken with Lenalidomide.
Dexamethasone (Decadron): This steroid is often used with Lenalidomide to treat multiple myeloma but can increase the risk of blood clots and other side effects.
Lenalidomide in Pregnancy
Is it safe to take Lenalidomide when pregnant?
No, it is not safe to take Lenalidomide during pregnancy. Lenalidomide is classified as a Category X drug, meaning it can cause severe birth defects or even result in the loss of the pregnancy. Women who are pregnant or planning to become pregnant must avoid Lenalidomide. If you are of childbearing age, it is essential to use two forms of contraception while taking this medication and for at least four weeks after discontinuing it. Regular pregnancy tests are also required throughout treatment to ensure safety.
Lenalidomide while Breastfeeding
Is it safe to take Lenalidomide while breastfeeding?
No, Lenalidomide is not recommended while breastfeeding. Although it is unclear whether Lenalidomide passes into breast milk, the potential for serious side effects in a nursing infant means breastfeeding should be avoided during treatment. If you are breastfeeding or planning to breastfeed, discuss alternative treatment options with your healthcare provider.
Estimated Cost of Lenalidomide
The cost of a 30-day supply of Lenalidomide can vary depending on the dosage and pharmacy. Without insurance, using a GoodRx coupon, the estimated cost of a 30-day supply of Lenalidomide (Revlimid) ranges from approximately $15,000 to $18,000. Prices may fluctuate, so it’s important to check with your pharmacy or use a discount service like GoodRx for the most up-to-date pricing.
Possible Alternatives to Lenalidomide
If Lenalidomide is not the right option for you, there are alternative treatments and lifestyle changes that may help manage your condition. Always consult your healthcare provider before making any changes to your treatment plan. You can also schedule a telemedicine appointment with one of our providers to explore your options.
Lenalidomide Alternatives for Multiple Myeloma
Alternative treatments for multiple myeloma may include medications such as Bortezomib (Velcade) or Carfilzomib (Kyprolis). Other options include stem cell transplants and radiation therapy. Additionally, maintaining a healthy diet and engaging in regular exercise can support overall well-being.
Lenalidomide Alternatives for Myelodysplastic Syndromes
Treatment options for myelodysplastic syndromes may include Azacitidine (Vidaza) or Decitabine (Dacogen). Blood transfusions and bone marrow transplants are also potential treatments. Managing stress and taking steps to avoid infections are important lifestyle adjustments that can improve quality of life.
Lenalidomide Alternatives for Mantle Cell Lymphoma
Alternatives for mantle cell lymphoma may include Ibrutinib (Imbruvica) or Acalabrutinib (Calquence). Chemotherapy and radiation therapy are also common treatment options. Staying active and eating a balanced diet can help support your overall health during treatment.
Lenalidomide Alternatives for Chronic Lymphocytic Leukemia
Other medications for chronic lymphocytic leukemia may include Venetoclax (Venclexta) or Ibrutinib (Imbruvica). Regular monitoring and maintaining a healthy lifestyle can help manage symptoms and improve outcomes.
Lenalidomide Alternatives for Follicular Lymphoma
Rituximab (Rituxan) and Obinutuzumab (Gazyva) are potential alternatives for follicular lymphoma. Radiation therapy and chemotherapy are also commonly used treatments. Staying physically active and managing stress can enhance your quality of life during treatment.
Lenalidomide Alternatives for Non-Hodgkin Lymphoma
Treatment for non-Hodgkin lymphoma may include Rituximab (Rituxan) or chemotherapy. Incorporating regular exercise and a healthy diet into your routine may help manage symptoms and improve overall well-being.
Lenalidomide Alternatives for Amyloidosis
Alternatives for amyloidosis include Bortezomib (Velcade) or Daratumumab (Darzalex). Stem cell transplants may also be considered. A low-sodium diet and regular physical activity can help manage symptoms and improve your quality of life.
Lenalidomide Alternatives for Acute Myeloid Leukemia
Treatment options for acute myeloid leukemia may include Cytarabine or Daunorubicin. Bone marrow transplants and chemotherapy are also common approaches. Adopting a healthy lifestyle can support recovery and improve overall health.
Lenalidomide Alternatives for Peripheral T-cell Lymphoma
Alternatives for peripheral T-cell lymphoma may include Pralatrexate (Folotyn) or Romidepsin (Istodax). Chemotherapy and radiation therapy are also frequently used. Maintaining a nutritious diet and staying physically active can contribute to better health outcomes.
Lenalidomide Alternatives for Waldenström Macroglobulinemia
Ibrutinib (Imbruvica) or Rituximab (Rituxan) may be alternatives for Waldenström macroglobulinemia. Plasmapheresis and chemotherapy are also common treatments. Regular exercise and a balanced diet can help support your overall health during treatment.
Recent Updates on Lenalidomide Research
Recent studies have focused on expanding the use of Lenalidomide in combination with other therapies to treat various types of cancer. For example, ongoing research is exploring the effectiveness of Lenalidomide when used alongside monoclonal antibodies to treat multiple myeloma and other blood cancers. Additionally, researchers are investigating whether Lenalidomide can be used as a maintenance therapy to prolong remission in patients with certain cancers.
There is also growing interest in understanding how Lenalidomide can target specific genetic mutations in cancer cells, which could lead to more personalized treatment approaches. As research continues, new findings may further refine the use of Lenalidomide in cancer treatment. Be sure to discuss any new developments with your healthcare provider, or schedule a telemedicine appointment with one of our providers to learn more about how these updates might affect your treatment plan.
